Elevance Health PE Ratio 2010-2025 | ELV
Current and historical p/e ratio for Elevance Health (ELV) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Elevance Health PE ratio as of July 11, 2025 is 10.08.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Elevance Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-11 | 340.67 | 13.29 | |
| 2025-03-31 | 433.05 | $25.63 | 16.90 |
| 2024-12-31 | 365.75 | $25.61 | 14.28 |
| 2024-09-30 | 513.46 | $27.43 | 18.72 |
| 2024-06-30 | 533.44 | $28.52 | 18.70 |
| 2024-03-31 | 508.94 | $26.46 | 19.23 |
| 2023-12-31 | 461.33 | $25.17 | 18.33 |
| 2023-09-30 | 424.67 | $25.47 | 16.67 |
| 2023-06-30 | 431.88 | $26.70 | 16.18 |
| 2023-03-31 | 445.53 | $25.70 | 17.34 |
| 2022-12-31 | 495.46 | $24.79 | 19.99 |
| 2022-09-30 | 437.67 | $25.49 | 17.17 |
| 2022-06-30 | 463.75 | $24.94 | 18.59 |
| 2022-03-31 | 470.84 | $25.40 | 18.54 |
| 2021-12-31 | 443.06 | $24.72 | 17.92 |
| 2021-09-30 | 355.33 | $22.28 | 15.95 |
| 2021-06-30 | 362.80 | $17.02 | 21.32 |
| 2021-03-31 | 340.11 | $18.68 | 18.21 |
| 2020-12-31 | 303.22 | $17.91 | 16.93 |
| 2020-09-30 | 252.90 | $19.34 | 13.08 |
| 2020-06-30 | 246.74 | $23.02 | 10.72 |
| 2020-03-31 | 212.34 | $18.47 | 11.50 |
| 2019-12-31 | 281.43 | $18.44 | 15.26 |
| 2019-09-30 | 223.10 | $16.43 | 13.58 |
| 2019-06-30 | 261.39 | $15.50 | 16.86 |
| 2019-03-31 | 265.04 | $15.12 | 17.53 |
| 2018-12-31 | 241.91 | $14.20 | 17.04 |
| 2018-09-30 | 251.79 | $17.26 | 14.59 |
| 2018-06-30 | 218.09 | $16.44 | 13.27 |
| 2018-03-31 | 200.64 | $15.62 | 12.84 |
| 2017-12-31 | 204.82 | $14.36 | 14.26 |
| 2017-09-30 | 172.32 | $11.06 | 15.58 |
| 2017-06-30 | 170.12 | $10.56 | 16.11 |
| 2017-03-31 | 149.03 | $10.31 | 14.45 |
| 2016-12-31 | 129.05 | $9.21 | 14.01 |
| 2016-09-30 | 111.96 | $8.52 | 13.14 |
| 2016-06-30 | 116.74 | $8.65 | 13.50 |
| 2016-03-31 | 122.93 | $8.87 | 13.86 |
| 2015-12-31 | 122.73 | $9.33 | 13.15 |
| 2015-09-30 | 122.66 | $10.45 | 11.74 |
| 2015-06-30 | 143.19 | $10.24 | 13.98 |
| 2015-03-31 | 134.19 | $9.67 | 13.88 |
| 2014-12-31 | 108.75 | $8.98 | 12.11 |
| 2014-09-30 | 103.16 | $7.67 | 13.45 |
| 2014-06-30 | 92.46 | $7.61 | 12.15 |
| 2014-03-31 | 85.19 | $7.69 | 11.08 |
| 2013-12-31 | 78.68 | $8.18 | 9.62 |
| 2013-09-30 | 70.91 | $9.20 | 7.71 |
| 2013-06-30 | 69.11 | $9.19 | 7.52 |
| 2013-03-31 | 55.65 | $8.49 | 6.56 |
| 2012-12-31 | 50.88 | $8.13 | 6.26 |
| 2012-09-30 | 48.20 | $7.58 | 6.36 |
| 2012-06-30 | 52.75 | $7.33 | 7.20 |
| 2012-03-31 | 60.76 | $7.28 | 8.35 |
| 2011-12-31 | 54.30 | $7.19 | 7.55 |
| 2011-09-30 | 53.31 | $7.63 | 6.99 |
| 2011-06-30 | 64.07 | $7.57 | 8.46 |
| 2011-03-31 | 56.58 | $7.39 | 7.66 |
| 2010-12-31 | 45.93 | $6.91 | 6.65 |
| 2010-09-30 | 45.75 | $11.46 | 3.99 |
| 2010-06-30 | 39.52 | $11.15 | 3.54 |
| 2010-03-31 | 52.00 | $10.87 | 4.78 |
| 2009-12-31 | 47.08 | $10.07 | 4.68 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $78.142B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.751B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| HealthEquity (HQY) | United States | $8.405B | 36.81 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |